Replies to post #213441 on NorthWest Biotherapeutics Inc (NWBO)

[GD]

You know Dr Richard Pazdur killed DNDN's positive committee vote for
approval on the first round process, now Dr. Pazdur is Director, Oncology
Center of Excellence, responsible for leading the effort to develop and
execute an integrated regulatory approach to enhance the cross-center
coordination of oncology product clinical review. If DAVax OS is not
SS, what Dr. Pazdur will do with NWBO? This is the major question I
have now.